BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36432161)

  • 1. High-Throughput Metabolic Soft-Spot Identification in Liver Microsomes by LC/UV/MS: Application of a Single Variable Incubation Time Approach.
    Zhu Y; Chen G; Zhang K; Chen C; Chen W; Zhu M; Jiang H
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36432161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of stable isotope labeled probes to facilitate liquid chromatography/mass spectrometry based high-throughput screening of time-dependent CYP inhibitors.
    Dasgupta M; Tang W; Caldwell GW; Yan Z
    Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2177-85. PubMed ID: 20583325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sensitive and high-throughput LC-MS/MS method for inhibition assay of seven major cytochrome P450s in human liver microsomes using an in vitro cocktail of probe substrates.
    Liu LY; Han YL; Zhu JH; Yu Q; Yang QJ; Lu J; Guo C
    Biomed Chromatogr; 2015 Mar; 29(3):437-44. PubMed ID: 25098274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-injection workflow for a liquid chromatography/LTQ-Orbitrap system to complete in vivo biotransformation characterization: demonstration with buspirone metabolite identification.
    Li AC; Ding J; Jiang X; Denissen J
    Rapid Commun Mass Spectrom; 2009 Sep; 23(18):3003-12. PubMed ID: 19681099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolite characterization in drug discovery utilizing robotic liquid-handling, quadruple time-of-flight mass spectrometry and in-silico prediction.
    Nassar AE; Adams PE
    Curr Drug Metab; 2003 Aug; 4(4):259-71. PubMed ID: 12871044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro metabolic stability and metabolite profiling of TJ0711 hydrochloride, a newly developed vasodilatory β-blocker, using a liquid chromatography-tandem mass spectrometry method.
    Huang J; Si L; Fan Z; Hu L; Qiu J; Li G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3386-92. PubMed ID: 21963275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Electro-Activated Dissociation Fragmentation Technique to Identifying Glucuronidation and Oxidative Metabolism Sites of Vepdegestrant by Liquid Chromatography-High Resolution Mass Spectrometry.
    He Y; Hou P; Long Z; Zheng Y; Tang C; Jones E; Diao X; Zhu M
    Drug Metab Dispos; 2024 Jun; 52(7):634-643. PubMed ID: 38830773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated approach for profiling oxidative metabolites and glutathione adducts using liquid chromatography coupled with ultraviolet detection and triple quadrupole-linear ion trap mass spectrometry.
    Chen G; Cheng Z; Zhang K; Jiang H; Zhu M
    J Pharm Biomed Anal; 2016 Sep; 129():482-491. PubMed ID: 27497649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic soft spot identification and compound optimization in early discovery phases using MetaSite and LC-MS/MS validation.
    Trunzer M; Faller B; Zimmerlin A
    J Med Chem; 2009 Jan; 52(2):329-35. PubMed ID: 19108654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolite Identification of a Novel Anti-Leishmanial Agent OJT007 in Rat Liver Microsomes Using LC-MS/MS.
    Rincon Nigro ME; Du T; Gao S; Kaur M; Xie H; Olaleye OA; Liang D
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of a fluorous derivatization method for characterization of glutathione-trapped reactive metabolites with liquid chromatography-tandem mass spectrometry analysis.
    Nishijo N; Hayama T; Tomita R; Yamaguchi M; Fujioka T
    J Chromatogr A; 2020 Jul; 1622():461160. PubMed ID: 32450990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput, 384-well, LC-MS/MS CYP inhibition assay using automation, cassette-analysis technique, and streamlined data analysis.
    Halladay JS; Delarosa EM; Tran D; Wang L; Wong S; Khojasteh SC
    Drug Metab Lett; 2011 Aug; 5(3):220-30. PubMed ID: 21867481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of ten cytochrome P450 enzyme activities with 12 probe substrates in human liver microsomes using cocktail incubation and liquid chromatography-tandem mass spectrometry.
    Kim HJ; Lee H; Ji HK; Lee T; Liu KH
    Biopharm Drug Dispos; 2019 Apr; 40(3-4):101-111. PubMed ID: 30730576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tentative identification of in vitro metabolites of 5-APDB, a synthetic benzofuran, by LC-Q/TOF-MS.
    Park JS; Rehman SU; Kim IS; Choi MS; Lee JS; In S; Yoo HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1033-1034():296-300. PubMed ID: 27595649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A semi-automated method for the integrated evaluation of half-life and metabolic soft spots of discovery compounds.
    Grubb MF; Humphreys WG; Josephs JL
    Bioanalysis; 2012 Jul; 4(14):1747-61. PubMed ID: 22877221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An automated, high-throughput, 384 well Cytochrome P450 cocktail IC50 assay using a rapid resolution LC-MS/MS end-point.
    Youdim KA; Lyons R; Payne L; Jones BC; Saunders K
    J Pharm Biomed Anal; 2008 Sep; 48(1):92-9. PubMed ID: 18584988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel approach to perform metabolite screening during the quantitative LC-MS/MS analyses of in vitro metabolic stability samples using a hybrid triple-quadrupole linear ion trap mass spectrometer.
    Shou WZ; Magis L; Li AC; Naidong W; Bryant MS
    J Mass Spectrom; 2005 Oct; 40(10):1347-56. PubMed ID: 16206149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a LC-MS/MS method for the in vitro analysis of 1-hydroxymidazolam in human liver microsomes: application for determining CYP3A4 inhibition in complex matrix mixtures.
    Mooiman KD; Maas-Bakker RF; Rosing H; Beijnen JH; Schellens JH; Meijerman I
    Biomed Chromatogr; 2013 Sep; 27(9):1107-16. PubMed ID: 23674377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cytochrome P450 inhibition assays using human liver microsomes by a cassette analysis /LC-MS/MS.
    Zambon S; Fontana S; Kajbaf M
    Drug Metab Lett; 2010 Aug; 4(3):120-8. PubMed ID: 20642444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of in vitro metabolites of TM-2, a potential antitumor drug, in rat, dog and human liver microsomes using liquid chromatography/tandem mass spectrometry.
    Men L; Zhao Y; Lin H; Yang M; Liu H; Tang X; Yu Z
    Rapid Commun Mass Spectrom; 2014 Oct; 28(20):2162-70. PubMed ID: 25178720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.